Oramed gets third Australia patent for oral Exenatide - 1 views
-
Alex Parker on 13 Mar 14Israel-based clinical-stage pharmaceutical firm Oramed Pharmaceuticals has received its third patent in Australia for oral administration of exenatide from the Australian government's patent office 'IP Australia'.